BioSpace News Archive

Press Releases

Palleon Pharmaceuticals and Henlius Collaborate to Advance Glycan Editing as a Treatment for Autoimmune Diseases

December 19, 2024
·
5 min read
Press Releases

Data and Safety Monitoring Board Reviews Interim Safety Data of Phase 2 Subjects of OCU410 ArMaDa Clinical Trial for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration

December 19, 2024
·
6 min read
Press Releases

NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders

December 19, 2024
·
8 min read
Press Releases

Bristol Myers Squibb to Report Results for Fourth Quarter 2024 on February 6, 2025

December 19, 2024
·
1 min read
Press Releases

P3 Partners Oral Surgery Launches Ambitious Practice Acquisition Campaign, Seeking Passionate Oral and Maxillofacial Surgeons to Join Our Growing Team

December 19, 2024
·
4 min read
Press Releases

Merck Announces Topline Results from Pivotal Phase 3 Trials Evaluating Investigational, Once-Daily, Oral, Two-Drug, Single-Tablet Regimen of Doravirine/Islatravir (DOR/ISL) for the Treatment of Adults with Virologically Suppressed HIV-1 Infection

December 19, 2024
·
16 min read
Press Releases

Polyrizon Appoints Dr. Michal Meir as Senior Director of Regulatory and Clinical Affairs

December 19, 2024
·
4 min read
Press Releases

Clearside Biomedical Announces Publication of Critical Insights into Retinal Drug Development in the Peer-Reviewed Scientific Journal, Eye

December 19, 2024
·
3 min read
Press Releases

Lifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder Treatment

December 19, 2024
·
5 min read
Press Releases

Nurix Therapeutics Receives U.S. FDA Fast Track Designation for NX-5948 for the Treatment of Relapsed or Refractory Waldenstrom’s Macroglobulinemia

December 19, 2024
·
8 min read